Zurcher Kantonalbank (Zurich Cantonalbank) Hutchmed (China) LTD Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$12.08 - $18.56 $10,557 - $16,221	-874 Reduced 99.54%	4 $0
Q4 2023 Jan 30, 2024	SELL	$16.25 - $20.23 $1,820 - $2,265	-112 Reduced 11.31%	878 $15,000
Q3 2023 Oct 25, 2023	SELL	$11.85 - $16.95 $3,874 - $5,542	-327 Reduced 24.83%	990 $16,000
Q2 2023 Aug 07, 2023	SELL	$10.78 - $17.73 $3,622 - $5,957	-336 Reduced 20.33%	1,317 $15,000
Q1 2023 May 08, 2023	BUY	$13.02 - $19.87 $12,564 - $19,174	965 Added 140.26%	1,653 $21,000
Q4 2022 Feb 01, 2023	SELL	$7.65 - $15.51 $123,004 - $249,385	-16,079 Reduced 95.9%	688 $10,000
Q1 2022 Apr 21, 2022	BUY	$15.52 - $35.65 $13,843 - $31,799	892 Added 5.62%	16,767 $317,000
Q4 2021 Feb 01, 2022	SELL	$28.89 - $35.33 $482,463 - $590,011	-16,700 Reduced 51.27%	15,875 $557,000
Q3 2021 Nov 15, 2021	SELL	$35.66 - $42.94 $203,261 - $244,758	-5,700 Reduced 14.89%	32,575 $1.19 Million
Q1 2021 May 03, 2021	BUY	$27.01 - $36.8 $172,864 - $235,519	6,400 Added 20.08%	38,275 $1.08 Million
Q4 2020 Jan 28, 2021	BUY	$27.51 - $34.36 $440,160 - $549,760	16,000 Added 100.79%	31,875 $1.02 Million
Q4 2018 Jan 25, 2019	BUY	$23.09 - $37.69 $366,553 - $598,328	15,875 New	15,875 $367,000

Others Institutions Holding HCM

# of Institutions

Shares Held

8.25M

Call Options Held

3.8K

Put Options Held

2.4K

Schroder Investment Management Group London, X0

3.02M
Shares

$54.4 Million
0.06% of portfolio
Allianz Asset Management Gmb H Munich, 2M

1.5M
Shares

$27 Million
0.04% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.15M
Shares

$20.7 Million
0.33% of portfolio
Acadian Asset Management LLC Boston, MA

389K
Shares

$7 Million
0.02% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

358K
Shares

$6.44 Million
0.0% of portfolio

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account